Sign In
Buy INCY
$119.80
-0.800 (-0.663%)
At Close: Aug 05, 2026
Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen
03:39pm, Thursday, 08'th Oct 2020
INDIANAPOLIS, Oct. 8, 2020 /PRNewswire via COMTEX/ --
INDIANAPOLIS, Oct. 8, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY)...
Pune, Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) -- Global vitiligo treatment market is likely to gain impetus from an ever rising demand for innovative and...
Pune, Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) --
Pune, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Global vitiligo treatment market is likely to gain impetus from an...
Oct 08, 2020 (The Expresswire) --
Global “Hodgkin's Lymphoma Treatment Market” report gives a historical overview of the Hodgkin's Lymphoma Treatment market...
Oct 08, 2020 (The Expresswire) --
The Global "Hodgkin Lymphoma Treatment Market" is anticipated to rise at a considerable rate during the forecast period,...
Kodiak Initiates Phase 3 Trial, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:KOD)
06:52am, Thursday, 08'th Oct 2020
Kodiak Sciences reports initiation of Phase 3 trial of KSI-301. Incyte announces peptide-centric strategic collaboration with Nimble.
Oct 07, 2020 (The Expresswire) --
"Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Janus Kinase (JAK) Inhibitors...
SHANGHAI and SAN FRANCISCO, Oct 06, 2020 (GLOBE NEWSWIRE via COMTEX) --
SHANGHAI and SAN FRANCISCO, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited...
Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics
04:48pm, Monday, 05'th Oct 2020
Nimble Therapeutics Inc. today announced the company has entered into a strategic collaboration with Incyte (NASDAQ: INCY) to discover first-in-class peptide...
Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics
04:00pm, Monday, 05'th Oct 2020
Nimble Therapeutics Inc. today announced the company has entered into a strategic collaboration with Incyte (NASDAQ: INCY) to discover first-in-class peptide...
Three Attractive Health Care Growth Stocks
12:00am, Sunday, 04'th Oct 2020
Healthcare stocks have gained nearly 18.0% in the first nine months of this year, compared to the S&P 500 index’s gain of 3.2% over the same time frame. While the coronavirus pandemic has been disru
Here are the biggest winners in a solid third quarter for U.S. stocks
04:02pm, Wednesday, 30'th Sep 2020
Gains were spread across tech, materials, industrials and retailers.
Leap Therapeutics Initiates Trial, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:LPTX)
07:42pm, Friday, 25'th Sep 2020
Leap Therapeutics initiates Phase 2a trial for DKN-01. MacroGenics reports progress on MGA012 development.
Global Hidradenitis Suppurativa (HS) Market Insights, Epidemiology and Market Forecasts, 2017-2019 & 2020-2030 - ResearchAndMarkets.com
12:00am, Wednesday, 23'rd Sep 2020
The
Sep 22, 2020 (The Expresswire) --
Global “Squamous Non-Small Cell Lung Cancer Therapeutics Market” Report discusses about the important developments...
